Monash University researchers have led an international study that has uncovered an unexpected link between constipation and an increased risk of...
Vous n'êtes pas connecté
People with type 2 diabetes face a high risk of serious health issues such as heart attacks, strokes, heart failure, and severe kidney disease. However, researchers at Monash University and other institutions have identified a medication that helps reduce these risks while being cost-effective. The drug, called sodium-glucose co-transporter 2 inhibitors (SGLT2is), is already known […]
Monash University researchers have led an international study that has uncovered an unexpected link between constipation and an increased risk of...
MONDAY, Aug. 12, 2024 -- For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent...
Managing blood sugar levels is crucial for people with diabetes, but even those without diabetes can benefit from keeping their blood sugar in check....
High blood pressure, also known as hypertension, is a common health condition that affects millions of people worldwide. It’s often called the...
Hypertension, or high blood pressure, is a well-known health issue that can lead to serious problems like heart disease, stroke, and kidney failure....
Highlights: Tirzepatide significantly lowers hospitalization and death risks in heart failure patients The drug
A recent study from the Baker Heart and Diabetes Institute and other collaborators has highlighted a promising new approach to preventing serious...
Chronic renal failure, also known as chronic kidney disease (CKD), is a condition in which the kidneys gradually lose their ability to function...
Researchers from Thomas Jefferson University have found that a combination of two diabetes drugs, dapagliflozin and exenatide, continues to...
Tirzepatide may reduce hospitalizations, improve symptoms, and decrease death risks in heart failure patients, offering new hope for those with...